ElsevierDrugInformation
Ribavirin Nebulizer Solution
Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.
RIBAVIRIN (rye ba VYE rin) treats infections caused by the respiratory syncytial virus (RSV). It works by limiting the spread of the virus inside the body. It belongs to a group of medications called antivirals. It will not treat colds, the flu, or infections caused by bacteria.
This medication is for inhalation through the mouth. It is given by your care team in a hospital setting.
Talk to your care team about the use of this medication in children. While it may be prescribed for children as young as infants for selected conditions, precautions do apply.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
This medication is given in a hospital or clinic. It will not be stored at home.
They need to know if you have any of these conditions:
Do not take this medication with the following:
This medication may also interact with the following:
This does not apply. This medication is not for regular use.
Your condition will be monitored carefully while you are receiving this medication.
Visitors and others are at risk of exposure to this medication by breathing mist from the air. Talk to the care team for more information. If you are pregnant or breast-feeding, talk with your care team before visiting a patient who is on this medication.
Talk to your care team if you wish to become pregnant or think you might be pregnant. This medication may cause serious birth defects if taken during pregnancy.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.